Floatz logo

CLOMIPHENE CITRATE

Hypoandrogenism

University of Sao PauloSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Hypoandrogenism cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
University of Sao Paulo General Hospital
Phase 4BB
TESTOSTERONE ENANTATE
Tulane University
Phase 4BB
TESTOSTERONE CIPIONATE
University of Miami
Phase 4B
TESTOSTERONE UNDECYLATE
University of Sao Paulo General Hospital
Phase 3B
Recombinant Ephb4-Hsa Fusion Protein
Northwestern University
Phase 2CCC

View all 18 →

Same molecule, other indications

CLOMIPHENE CITRATE is also rated in:

infertility disorderDormant
A
Indicative ·
81 / 100
View asset →
anovulationDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →